Advanced NanoTherapies
Drug-coated balloons engineered to deliver stent-like patency and restenosis prevention with long-term release of synergistic drugs.
Launch date
Employees
Market cap
-
Enterprise valuation
$36m (Public information from Aug 2023)
Mountain View California (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
$5.3m Valuation: $8.0m | Seed | ||
* | N/A | $7.2m | Series A |
* | N/A | $4.0m Valuation: $36.0m | Series A |
| Total Funding | $16.5m | ||
Recent News about Advanced NanoTherapies
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.